
Fastest journal in Gastroenterology
Alimentary Pharmacology & Therapeutics
Edited by:
R.E. Pounder and W.L. Peterson
Impact Factor: 3.710
Alimentary Pharmacology & Therapeutics is the international journal concerned with the effects of drugs on the human gastrointestinal and hepato-biliary systems, particularly with relevance to clinical practice.
The Journal accepts original papers concerned with all aspects of basic and clinical pharmacology, pharmacokinetics and the therapeutic use of drugs in the alimentary tract including the liver, gall bladder and pancreas.
TopNews and Announcements
LATEST ISSUE SUBMIT MANUSCRIPT HERE
URGENT Preprint: 'Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease'
Virtual Issues
Free access for two collections of recent, interesting papers from AP&T:
Key articles within hepatology
Key articles within IBD
2008 Impact Factor
Alimentary Pharmacology & Therapeutics 2008 Impact Factor:
When the 2008 Impact Factors were announced by Thomson Reuters, we were very surprised to see the Impact Factor for AP&T had dropped from the 2007 figure of 3.201 to 1.215.
Thomson Reuters has agreed that a mistake was made in their calculation, and the revised correct AP&T Impact Factor for 2008 is 3.71.
AP&T Total Citations in 2008: 11,304 [ranking it 8 in Gastroenterology & Hepatology]
Journal 2-y Impact Factor: (1087+1744)/(335+428) = 3.710 [ranking it 14 in Gastroenterology & Hepatology]
5-year IF = (1087+1744+1440+1572+1448)/(335+428+360+413+372) = 3.821 [ranking it 11 in Gastroenterology & Hepatology].
Immediacy Index: 253/268 = 0.944 [ranking it 9 in Gastroenterology & Hepatology]
Ten good reasons why authors prefer Alimentary Pharmacology & Therapeutics
- 2008 Impact Factor is 3.710; SCImago SJR 0.414 for 2007
- Quick decisions: submission to first decision in 14 days on average
- Superfast submission: costs $1,500 and guarantees first decision in 6 working days - but does not guarantee acceptance
- Fast publication: acceptance to print publication in an average of only 10 weeks
- 'Accepted Articles' (previously 'OnlineAccepted'): Read unedited articles online a few days after acceptance
- FREE PDF off-prints for all corresponding authors
- One-year electronic subscription and three-month print subscription for corresponding authors
- Submit your article online at http://mc.manuscriptcentral.com/apt
- Track articles through review and production using Manuscript Central and Author Services - check article status and receive alerts at key stages through review and production, from submission to publication online and in print
- AP&T reviewers contributed $34,785 to Médecins Sans Frontières in 2008.
Online content now available back to volume 1
All back issues of this journal are available online. Click here to browse contents and abstracts. For further information on how to access these issues visit our Librarian Site.
Online content now available free after 18 months!
Wiley-Blackwell publication ethics
The Best Practice Guidelines on Publication Ethics describe Wiley-Blackwell's position on the major ethical principles of academic publishing. They can be accessed at the following link: http://www.blackwellpublishing.com/publicationethics/
Free and low cost access in the Developing World
Free or low cost online access to this journal is available within institutions in the Developing World through Research4Life (the HINARI/AGORA/OARE initiatives).
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement.
TopHighlights
TOP TWENTY DOWNLOADS IN AUGUST FOR 2009 ARTICLES - PLEASE DOWNLOAD FREE OF CHARGE
Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents
Review article: diet and inflammatory bowel disease - epidemiology and treatment
Review article: the current and evolving treatment of colonic diverticular disease
Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers
Review article: the diagnosis and management of alcoholic hepatitis
Systematic review: hepatitis-associated aplastic anaemia - a syndrome associated with abnormal immunological function
Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomized controlled trials
Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C
Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy
Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease
Review article: Chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease
Systematic review: the epidemiology and clinical features of travellers' diarrhoea
Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia
Clinical trial: extended treatment duration of peginterferon-alpha2b plus ribavirin for 72 and 96 weeks in hepatitis C genotype 1-infected late responders
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients
The top 20 review articles from 2008 are now available to download FREE OF CHARGE:
Hepatology
Review article: current antiviral therapy of chronic hepatitis B
Review article: drug hepatotoxicity
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Review article: diagnosis and treatment of non-alcoholic fatty liver disease
Review article: management of ascites and associated complications in patients with cirrhosis
Review article: the modern management of portal hypertension primary and secondary prophylaxis of variceal bleeding in cirrhotic patients
Review article: novel therapeutic options for chronic hepatitis C
Probiotics and Prebiotics
Review article: prebiotics in the gastrointestinal tract
Review article: bifidobacteria as probiotic agents; physiological effects and clinical benefits
Review article: probiotics in gastrointestinal and liver diseases
Review article: probiotics and prebiotics in irritable bowel syndrome
Functional Disorders
Review article: gastroparesis
Review article: abdominal bloating and distension in functional gastrointestinal disorders - epidemiology and exploration of possible mechanisms
Inflammatory Bowel Disease
Review article: the evidence base for interventions used to maintain remission in Crohn's disease
Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease
Review article: the role of butyrate on colonic function
Review article: management of diverticulitis
Review article: altering the natural history of Crohn's disease; evidence for and against current therapies
GERD and Acid Suppression
Review article: respiratory manifestations of gastro-oesophageal reflux disease
Review article: the clinical pharmacology of proton pump inhibitors
